Banco de Sabadell’s DexCom DXCM Stock Holding History

Banco de Sabadell’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,060	Closed	-$144K	–	87
2021 Q3	$144K	Hold	1,060	–	–	0.1%	76
2021 Q2	$113K	Sell	1,060 -500	-32%	-$48K	0.08%	102
2021 Q1	$137K	Hold	1,560	–	–	0.01%	229
2020 Q4	$142K	Buy	+1,560	New	+$139K	0.02%	247

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Banco de Sabadell's DXCM Position: Q4 2021 in Review

Banco de Sabadell sold out of DexCom (DXCM) in Q4 2021, closing a stake of 1,060 shares — an estimated $144K sold.

Banco de Sabadell first reported a position in DXCM in Q4 2020 and held it in 4 quarters. The position peaked at $144K in Q3 2021. 930 funds tracked by Wall St. Rank hold DXCM as of Q4 2021.

Banco de Sabadell reported no remaining DexCom position as of Q4 2021 after selling out during the quarter.
Banco de Sabadell sold 1,060 DexCom shares in Q4 2021, an estimated $144K.
Banco de Sabadell first reported a position in DexCom in Q4 2020 and held it in 4 quarters.
Banco de Sabadell's DexCom position peaked at $144K in Q3 2021.
930 funds tracked by Wall St. Rank held DexCom as of Q4 2021.

Based on Banco de Sabadell's 13F filing for Q4 2021, filed 14 Feb 2022.